Time period given by analyst is Intra Day when Lupin Ltd. price can reach defined target.
Lupin Ltd., incorporated in the year 1983, is a Large Cap company (having a market cap of Rs 40592.59 Crore) operating in Pharmaceuticals sector.
Lupin Ltd. key Products/Revenue Segments include Pharmaceuticals, Export Incentives, Other Operating Revenue and Other Services for the year ending 31-Mar-2021.
Financials
For the quarter ended 30-09-2021, the company has reported a Consolidated Total Income of Rs 4164.14 Crore, down -3.11 % from last quarter Total Income of Rs 4298.02 Crore and up 7.88 % from last year same quarter Total Income of Rs 3859.96 Crore. Company has reported net profit after tax of Rs -2094.89 Crore in latest quarter.
Investment Rationale
Breached its 50 DMA and trading downwards on daily frame.
Promoter/FII Holdings
Promoters held 46.83 per cent stake in the company as of 30-Sep-2021, while FIIs owned 15.66 per cent, DIIs 24.46 per cent.
(Disclaimer: Recommendations given in this section or any reports attached herein are authored by an external party. Views expressed are that of the respective authors/entities. These do not represent the views of Economic Times (ET). ET does not guarantee, vouch for, endorse any of its contents and hereby disclaims all warranties, express or implied, relating to the same. Please consult your financial adviser and seek independent advice.
